Navigation Links
DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
Date:5/29/2013

Chicago, IL (PRWEB) May 29, 2013

The birth control safety advocates at DrugRisks.com are announcing a new resource center for patients who have taken the contraceptives Yaz or Yasmin. The site contains warnings about the drugs’ alleged link to blood clots and compensation offered by Bayer for victims.

DrugRisks was created to give patients taking popular prescription drugs like Yaz and Yasmin the latest warnings, recalls, studies and legal news. With access to clear information, patients can discuss side effect concerns with their doctor and decide if they need legal advice.

The resource center contains studies from the British Medical Journal* and FDA** showing patients taking birth control pills containing drospirenone, like Yaz and Yasmin, may have an increased risk of developing blood clots.

With a growing number of patients filing a Yaz lawsuit alleging blood clot injuries, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

DrugRisks has also learned that the maker of Yaz and Yasmin, Bayer, has spent nearly $1 billion so far to settle around 4,800 claims alleging Yaz blood clots, and will continue to evaluate new claims for settlement on a case-by-case basis***.

Although a federal court recently opened up competition for Yaz from generics****, DrugRisks cautions patients that blood clots have been linked to the chemical drospirenone, which is used in both brand name and generic formulations.

Lawyers are still helping those affected file a claim. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisks Center or speak with a lawyer about their legal options.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to Yaz or Yasmin, or to speak with a lawyer.

*BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
**FDA, 10/27/11, fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
***Bayer 2/28/13; annualreport2012.bayer.com/en/legal-risks.aspx
****Business Week, 4/16/13; businessweek.com/news/2013-04-16/bayer-patent-on-yaz-birth-control-pill-ruled-invalid

Read the full story at http://www.prweb.com/releases/DrugRisks-Yaz-Side/Effects-Center/prweb10777913.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
2. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
3. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
4. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
5. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
6. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
7. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
8. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
9. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
10. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
11. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... critical to ensuring high-quality results and maintaining GMP and USP compliance. In a ... in accordance with GMP requirements " these requirements are explained. The challenge ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists ... to quality care can be limited while the desire to conquer breakouts and eliminate ... acne care for every customer online, today released its inaugural survey on the State ...
(Date:3/28/2017)... Ohio (PRWEB) , ... March 28, 2017 , ... Columbus ... was selected as one of few medical professionals in the country to sit on ... Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... Public ... and across a variety of business channels. , While many results are clear, ... any public relations program. , When it comes to measurement, firms should always ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  "US Cancer Generics ... the various indicators and trend analysis related to ... in mainstream pharmaceutical market in US. The report ... the growth on cancer generics drugs in recent ... saving of billions of dollars for various stake ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
(Date:3/28/2017)... , March 28, 2017 ... consolidated vendor landscape, with the top three companies, namely ... accounting for a significant 49% of the overall market ... report. The vendor landscape is intensely competitive and has ... the overall market. These factors have restricted the entry ...
Breaking Medicine Technology: